Dr. Liau didn't even care to do a prerecorded intro. Then she could've let Mulholland takeover. It is her baby after all! My guess is UCLA legal doesn't want her associated with NWBO for whatever reason. Perhaps SEC entanglement issues or maybe they caught wind that Powers used the Plll to build private CDMO's instead of running more trials?? Cognate did practically nothing for DCVAX in the long run, after all.
Endpoint changes aside, I think the unique criteria requiring full to near complete resection combined with lack of data on non-crossover, is problematic. The question about steroid use is problematic. The unexplained enrollment halt that presenters fail to ever mention is seriously problematic, that we don't yet know if long term survivors moved on to other treatments is problematic. The lack of a journal mention by now, as the company runs on fumes, is very problematic.
News 
Market Data 
Discover 
AI
